BARCLAYS PLC - NEUROCRINE BIOSCIENCES INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$705
+279.0%
475,000
+225.3%
0.00%
Q2 2023$186
+55.0%
146,000
+64.0%
0.00%
Q1 2023$120
-88.9%
89,000
-87.0%
0.00%
Q4 2022$1,077
-99.9%
685,000
+31.2%
0.00%
-100.0%
Q3 2022$731,000
+18.1%
522,000
+12.3%
0.00%
Q2 2022$619,000
+20.4%
465,000
+17.1%
0.00%
Q1 2022$514,000
-72.1%
397,000
-73.3%
0.00%
Q4 2021$1,842,000
+6251.7%
1,486,000
+6654.5%
0.00%
Q3 2021$29,000
-93.6%
22,000
-93.5%
0.00%
Q2 2021$452,000
+11.6%
340,000
+13.7%
0.00%
Q1 2021$405,000
-83.9%
299,000
-83.6%
0.00%
-100.0%
Q4 2020$2,517,000
-78.2%
1,818,000
-78.3%
0.00%
-85.7%
Q3 2020$11,543,000
+420.0%
8,373,000
+382.3%
0.01%
+250.0%
Q1 2020$2,220,000
+17.5%
1,736,000
+26.3%
0.00%
+100.0%
Q3 2019$1,889,000
-85.9%
1,375,000
-87.7%
0.00%
-90.0%
Q4 2018$13,392,000
+108.1%
11,219,000
+197.2%
0.01%
+150.0%
Q3 2018$6,435,000
+638.0%
3,775,000
+525.0%
0.00%
+300.0%
Q2 2018$872,000604,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Myriad Asset Management Ltd. 17,500,000$29,890,0004.31%
SSI INVESTMENT MANAGEMENT LLC 8,987,000$15,319,0001.18%
CSS LLC/IL 14,955,000$25,561,0001.09%
SHENKMAN CAPITAL MANAGEMENT INC 3,983,000$6,799,0000.82%
Verition Fund Management LLC 6,425,000$10,968,0000.39%
ADVENT CAPITAL MANAGEMENT /DE/ 9,495,000$16,214,0000.33%
MACKAY SHIELDS LLC 21,609,000$36,877,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 12,776,000$21,819,0000.25%
Calamos Advisors LLC 24,100,000$41,405,0000.23%
OAKTREE CAPITAL MANAGEMENT LP 8,895,000$15,184,0000.20%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders